The US Food and Drug Administration (FDA) is testing prototypes for a new front-of-pack symbol demoting when a food or beverage can be deemed “healthy.”
The FDA is soliciting comments on several proposed symbols, which all bear the words “FDA” and “Healthy.” The symbols would be voluntarily available to marketers on products that meet FDA standards to be called “healthy.”
The action is separate from FDA’s efforts to redefine what’s “healthy,” which has been going on for years.
In the Federal Register notice, the FDA noted that its research in coming up with the symbol is not dependent on specific criteria for ‘healthy’” and therefore does not have to wait until there is a final, updated regulatory definition.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



